JCE vs V
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is severely compromised with a Piotroski F-Score of 1/9, indicating significant fundamental weakness. However, this is contrasted by a strong value proposition, with the stock trading at a P/E of 5.93 and below its intrinsic value of $18.90. While long-term price performance is robust (+72.6% over 5 years), the current technical trend is heavily bearish (10/100). The investment case rests on a high dividend yield of 8.49% and deep value, offset by poor short-term momentum and weak health metrics.
V shows bullish fundamentals based on deterministic rules. Financial strength is strong (F-Score 6/9). Key strengths include strong valuation and growth metrics.
Compare Another Pair
Related Comparisons
JCE vs V: Head-to-Head Comparison
This page compares Nuveen Core Equity Alpha Fund (JCE) and Visa Inc. (V) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.